368833-94-7 Usage
Uses
Used in Pharmaceutical Industry:
1,5-Dimethyl-1H-imidazole-4-carbaldehyde is used as a building block or intermediate in the synthesis of pharmaceutical compounds for its potential biological activity. Imidazoles are known for their wide range of applications in medicine, including antifungal, antibacterial, and anti-inflammatory properties.
Used in Agrochemical Industry:
In the agrochemical sector, 1,5-Dimethyl-1H-imidazole-4-carbaldehyde is utilized as a component in the development of pesticides or other agrochemicals, leveraging the imidazole structure's ability to interact with biological systems and target pests or diseases.
Used in Dye Industry:
1,5-Dimethyl-1H-imidazole-4-carbaldehyde is employed as a precursor or intermediate in the production of dyes, taking advantage of the imidazole ring's ability to form stable chromophores, which contribute to color and stability in various dye applications.
Used in Polymer Synthesis:
1,5-Dimethyl-1H-imidazole-4-carbaldehyde is used as a monomer or a component in the synthesis of polymers, where the imidazole ring can contribute to the polymer's properties, such as thermal stability, conductivity, or specific binding capabilities.
Check Digit Verification of cas no
The CAS Registry Mumber 368833-94-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,8,8,3 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 368833-94:
(8*3)+(7*6)+(6*8)+(5*8)+(4*3)+(3*3)+(2*9)+(1*4)=197
197 % 10 = 7
So 368833-94-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O/c1-5-6(3-9)7-4-8(5)2/h3-4H,1-2H3
368833-94-7Relevant articles and documents
COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
-
Paragraph 00430, (2016/10/31)
Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors described herein.
Novel farnesyl protein transferase inhibitors as antitumor agents
-
Page 465, (2010/02/07)
Disclosed are novel tricyclic compounds represented by the formula (1.0): and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.